[Joint Filing Agreement This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is]
[Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F BEIJING, May 16, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA)(“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it is delaying its]
[W ashington FORM 8-A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 39 Shangdi Xi Road, Haidian District, Beijing 100]
[W ashington FORM 8-A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 39 Shangdi Xi Road, Haidian District, Beijing 100]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent AMENDMENT TO RIGHTS AGREEMENT Effective as of March 24, 2017 Amendment Rights Agreement Company Rights Agent This Amendment (this “ WHEREAS, the Company and the Rights Agent have heretofore executed and entered into the Rights A]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[Sinovac Reports Unaudited Third Quarter 2016 Financial Results BEIJING, Nov. 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter ended September 30, 2016. Mr. Weidong Yin, Chairman, Presid]
